CY1121034T1 - Μεθοδοι για την θεραπεια πρωκτικης ακρατειας χρησιμοποιωντας μυοβλαστες - Google Patents

Μεθοδοι για την θεραπεια πρωκτικης ακρατειας χρησιμοποιωντας μυοβλαστες

Info

Publication number
CY1121034T1
CY1121034T1 CY181101158T CY181101158T CY1121034T1 CY 1121034 T1 CY1121034 T1 CY 1121034T1 CY 181101158 T CY181101158 T CY 181101158T CY 181101158 T CY181101158 T CY 181101158T CY 1121034 T1 CY1121034 T1 CY 1121034T1
Authority
CY
Cyprus
Prior art keywords
methods
incontinence
myoblastes
anality
treatment
Prior art date
Application number
CY181101158T
Other languages
English (en)
Inventor
Rainer Marksteiner
Original Assignee
Innovacell Biotechnologie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovacell Biotechnologie Ag filed Critical Innovacell Biotechnologie Ag
Publication of CY1121034T1 publication Critical patent/CY1121034T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Prostheses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Η παρούσα εφεύρεση αφορά σε μεθόδους πρόληψης ή θεραπείας πρωκτικής ακράτειας που περιλαμβάνει έγχυση λαμβανόμενων από μυ κυττάρων εντός μιας πλευράς που ενδιαφέρει μέσω μιας διάταξης έγχυσης, όπου η θέση έγχυσης που ενδιαφέρει είναι μυϊκός ιστός ή είναι γειτονική προς μυϊκό-ιστό που παρέχει πρωκτική ακράτεια.
CY181101158T 2007-02-28 2018-11-20 Μεθοδοι για την θεραπεια πρωκτικης ακρατειας χρησιμοποιωντας μυοβλαστες CY1121034T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89209507P 2007-02-28 2007-02-28
US12/038,410 US20080208164A1 (en) 2007-02-28 2008-02-27 Methods for the treatment of anal incontinence
PCT/IB2008/000829 WO2008104883A1 (en) 2007-02-28 2008-02-28 Methods for the treatment of anal incontinence

Publications (1)

Publication Number Publication Date
CY1121034T1 true CY1121034T1 (el) 2019-12-11

Family

ID=39716752

Family Applications (1)

Application Number Title Priority Date Filing Date
CY181101158T CY1121034T1 (el) 2007-02-28 2018-11-20 Μεθοδοι για την θεραπεια πρωκτικης ακρατειας χρησιμοποιωντας μυοβλαστες

Country Status (13)

Country Link
US (1) US20080208164A1 (el)
EP (1) EP2120976B1 (el)
CY (1) CY1121034T1 (el)
DK (1) DK2120976T3 (el)
ES (1) ES2696532T3 (el)
HR (1) HRP20181728T1 (el)
HU (1) HUE039850T2 (el)
LT (1) LT2120976T (el)
PL (1) PL2120976T3 (el)
PT (1) PT2120976T (el)
SI (1) SI2120976T1 (el)
TR (1) TR201816313T4 (el)
WO (1) WO2008104883A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150247856A1 (en) * 2012-09-24 2015-09-03 Innovacell Bioyechnologie Ag Potency assay for skeletal muscle derived cells
CA3180026A1 (en) 2020-06-16 2021-12-23 Craig Joseph Cermak Parallel path puncture device guide and method
WO2023012334A1 (en) 2021-08-06 2023-02-09 Innovacell Ag Myogenic progenitor cells for use in an optimized method for the prevention and treatment of anal incontinence
WO2024047234A1 (en) 2022-09-02 2024-03-07 Universität Zürich Injection device

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130141A (en) * 1988-05-24 1992-07-14 Law Peter K Compositions for and methods of treating muscle degeneration and weakness
US5538722A (en) * 1989-06-13 1996-07-23 Stanford University Isolation, growth, differentiation and genetic engineering of human muscle cells
US5571083A (en) * 1994-02-18 1996-11-05 Lemelson; Jerome H. Method and system for cell transplantation
US6129761A (en) * 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US6866842B1 (en) * 1998-05-01 2005-03-15 University Of Pittsburgh Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction
WO2001032129A2 (en) * 1999-11-05 2001-05-10 Gerigene Medical Corporation Augmentation and repair of age-related soft tissue defects
MY130475A (en) * 2000-08-25 2007-06-29 Contura As Polyacrylamide hydrogel and its use as an endoprosthesis
US20090130066A1 (en) 2000-11-06 2009-05-21 Gerigene Medical Corporation Augmentation and repair of sphincter defects with cells including muscle cells
US20070078435A1 (en) * 2001-06-14 2007-04-05 Corbett Stone Tissue augmentation methods using a medical injection apparatus
WO2004055174A1 (fr) 2002-12-13 2004-07-01 Celogos Composition de milieu de culture, procede de culture, et myoblastes ainsi obtenus, et leurs utilisations
US7666177B2 (en) * 2003-09-15 2010-02-23 James Guest Method and system for cellular transplantation in the spinal cord
US7270655B2 (en) * 2005-01-14 2007-09-18 Haidukewych George J Autologous material delivery apparatus and method
US20060257445A1 (en) 2005-04-29 2006-11-16 Medtronic, Inc. Devices for augmentation of lumen walls
US20070224173A1 (en) * 2006-03-21 2007-09-27 Koullick Edouard A Nonexpansion Protocol for Autologous Cell-Based Therapies
EP1900810A1 (fr) 2006-09-15 2008-03-19 Celogos Methode d'extraction et de selection de cellules
US9121009B2 (en) * 2006-12-18 2015-09-01 University of Pittsburgh—Of the Commonweath System of Higher Education Muscle derived cells for the treatment of gastro-esophageal pathologies and methods of making and using the same

Also Published As

Publication number Publication date
HRP20181728T1 (hr) 2018-12-28
SI2120976T1 (sl) 2018-12-31
EP2120976A1 (en) 2009-11-25
HUE039850T2 (hu) 2019-02-28
DK2120976T3 (en) 2018-11-26
ES2696532T3 (es) 2019-01-16
LT2120976T (lt) 2018-11-26
PL2120976T3 (pl) 2019-02-28
EP2120976B1 (en) 2018-08-15
US20080208164A1 (en) 2008-08-28
PT2120976T (pt) 2018-11-26
WO2008104883A1 (en) 2008-09-04
WO2008104883A8 (en) 2008-11-06
TR201816313T4 (tr) 2018-11-21

Similar Documents

Publication Publication Date Title
CY1121034T1 (el) Μεθοδοι για την θεραπεια πρωκτικης ακρατειας χρησιμοποιωντας μυοβλαστες
CY1122984T1 (el) Καρβαμιδικες ενωσεις και μεθοδοι παρασκευης και χρησης τους
CY1122707T1 (el) Ετεροκυκλικοι αναστολεις γλουταμινασης
LTPA2019503I1 (lt) Modifikuotų T ląstelių, turinčių chimerinų antigeno receptorių, panaudojimas vėžio gydymui
EA201290727A1 (ru) Пирролбензодиазепины и их конъюгаты
EA201171367A1 (ru) Винилиндазолильные соединения
EA201101182A1 (ru) Новые аминоазагетероциклические карбоксамиды
DK2217322T3 (da) Indretning til stimulering af levende væv ved hjælp af mikroelektroder, aftageligt modul og anvendelse deraf
ECSP10010206A (es) Inhibidores de la replicación del virus de la imunodeficiencia humana
DK2245199T3 (da) Anvendelse af mikrovesikler i diagnosticering, prognosticering og behandling af medicinske sygdomme og tilstande
EA201290901A1 (ru) Фитоканнабиноиды для лечения злокачественной опухоли
EA201190280A1 (ru) Производные l-(пиперидин-4-ил)пиразола в качестве модуляторов gpr 119
DK2227257T3 (da) Anordninger til minimal-invasiv ekstraokular afgivelse af stråling til den posteriore del af øjet
ITVR20060113A1 (it) Dispositivo per il trattamento del tessuto adiposo sottocutaneo mediante shockwaves non foicalizzate e contrapposte
EA201270247A1 (ru) Способы применения с-мет-модуляторов
BR112012021071A2 (pt) método de tratamento do solo, aparelho de injeção, cabeçote do aparelho de injeção e combinação
EA201200218A1 (ru) Новые бициклические соединения мочевины
EA201200473A1 (ru) Замещенные (гетероарилметил)тиогидантоины
EA201101330A1 (ru) Замещенные пиримидины, предназначенные для лечения рака
BRPI0908635A8 (pt) composto, composição farmacêutica e método de tratamento de câncer
EA201070609A1 (ru) Способы лечения ожирения и ассоциированных с ожирением заболеваний и расстройств
DK2448606T3 (da) Biologisk materiale, som er egnet til terapi af osteoarthrosis, ligamentskader og behandling af ledsygdomme.
EA201200247A1 (ru) Новые азагетероциклические соединения
EA201000895A1 (ru) Композиции и способы для лечения лизосомных болезней
EA201100296A1 (ru) Новые фениламино-изоникотинамидные соединения